Exelixis, Inc. v. MSN Laboratories Private Limited et al

  1. October 15, 2024

    Judge Backs Exelixis Cancer Drug Patent Claims

    A Delaware federal judge on Tuesday rejected invalidity arguments against three Exelixis patents that MSN Laboratories Private Ltd. said it would be infringing with a proposed generic of blockbuster drug Cabometyx, while also finding that a fourth patent wasn't invalid nor was it infringed.

  2. October 19, 2023

    IP Forecast: NXP-Impinj Patent Battle Heads To Waco

    Jury selection in the first of three scheduled trials over dueling allegations of patent infringement between two chipmakers is set to kick off in Waco, Texas, making it the third court to preside over their microchips feud involving different patents this year. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.